ArticleJournal of pain research2025
Large-Channel Interlaminar Endoscopic Discectomy for Highly Migrated Lumbar Disc Herniation: Effectiveness and Safety.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Delta large-channel endoscopy versus unilateral biportal endoscopy for cervicothoracic junction disc herniation: a prospective randomized controlled trial.Journal of orthopaedic surgery and research · 2026Trial
- Comparison of clinical effectiveness between interlaminar and transforaminal endoscopic lumbar discectomy for L4/5 highly migrated lumbar disc herniation: a retrospective study with a minimum one year follow-up.BMC musculoskeletal disorders · 2026Article
- Percutaneous Endoscopic Lumbar Discectomy Serves as a Valuable Minimally Invasive Surgical Option for Adolescent Lumbar Disc Herniation: Mid-Term Outcomes from a Retrospective Cohort Study.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Highly migrated lumbar disc herniation (HM-LDH) presents a significant challenge for surgeons. This study aimed to assess the safety and clinical outcomes of large-channel interlaminar endoscopic discectomy for HM-LDH and compare it to open fenestration discectomy. Patients and Methods: Patients who underwent large-channel interlaminar endoscopic discectomy (group A) or open fenestration discectomy (group B) for HM-LDH between January 2021 and December 2023 were included. Radiological and clinical outcomes were evaluated over at least one year. Operation time, intraoperative blood loss, postoperative drainage, postoperative hospital stay, patient-reported outcomes and complications were compared between groups, independent sample Results: One hundred and thirty-six patients were retrospectively included in this study, with 84 in group A and 52 in group B, respectively. Although similar operative time was observed in group A and group B, group A was detected with significantly less intraoperative blood loss (17.6 ± 6.0 mL vs 101.7 ± 62.0 mL, P = 0.003) and shorter postoperative hospital stay (2.4 ± 0.6 days vs 5.2 ± 2.2 days, P < 0.001). Additionally, postoperative drainage was required in group B (35.9 ± 26.4 mL), but none in group A. Follow-up durations averaged 22.8 ± 4.9 months for group A and 20.2 ± 4.2 months for group B. Both groups achieved a significant improvement in VAS, ODI and EQ-5D scores without significant differences. No case experienced neurological deficits and reoperation after surgery in either group. The overall percentage of patients with good to excellent results according to modified MacNab criteria of group A was 95.2%, versus 92.3% of group B. Conclusion: For the treatment of HM-LDH, large-channel interlaminar endoscopic discectomy is an effective and safe treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.